Ablation therapy destroys breast cancer without scarring

July 22, 2004

NEW YORK CITY - Image-guided thermal techniques that kill tumors without open surgery or scarring may soon allow women diagnosed with breast cancer to avoid disfigurement to be rid of the disease. "We don't have to deform women in order to destroy their cancer," said Steven A. Harms, M.D., professor of radiology and director of imaging research, University of Arkansas for Medical Sciences in Little Rock.

"I believe this is a treatment that women will begin to demand because it offers everything," Dr. Harms said. "It's an effective outpatient procedure with minimal discomfort that delivers the ultimate cosmetic result: no scars and no deformity."

Ablation therapy utilizes ultrasound or magnetic resonance (MR) imaging to guide a thermal device to the site of a breast tumor. "Ultrasound is an easy guidance method. A high contrast, high resolution MRI is essential for defining the extent of the disease. This is a major revolution. We are seeing and treating breast cancer better than ever before," Dr. Harms said.

There are three types of thermal ablation:Dr. Harms spoke about the procedures today at a Radiological Society of North America (RSNA) media briefing on women's breast health.

"A key advantage of image-guided ablation is that the physician can visualize the ideal treatment zone and effectively destroy the tumor and a margin of tissue surrounding it," Dr. Harms said.

Dr. Harms and physicians at the University of Arkansas for Medical Sciences (UAMS) in Little Rock have performed over 50 thermal ablations on breast cancer patients followed by traditional surgery. Serial section MR images and pathological studies of the breasts indicated that the procedure successfully destroyed all of the cancerous cells.

As a result, UAMS plans to offer thermal ablation as a treatment for solitary small tumors (1.5 centimeters or smaller--about the size of a gumball). Following the procedure, patients typically receive radiation therapy and/or chemotherapy, just as they would following surgical treatment of breast cancer.

"Within a few days or weeks the inflammation goes away. After a year, there's nothing left to see. The patient looks like she did before she developed cancer," Dr. Harms said.

According to Dr. Harms, additional tools, clinical trials and physician training are needed before thermal ablation can become more widespread.
RSNA is an association of more than 35,000 radiologists, radiation oncologists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook, Ill. (http://www.rsna.org/media)

Radiological Society of North America

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.